- Home
- XRTX vs NDRA Comparison
XRTX vs NDRA Comparison
Compare XRTX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- NDRA
- Stock Information
- Founded
- XRTX 2011
- NDRA 2007
- Country
- XRTX Canada
- NDRA United States
- Employees
- XRTX N/A
- NDRA N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XRTX Health Care
- NDRA Health Care
- Exchange
- XRTX Nasdaq
- NDRA Nasdaq
- Market Cap
- XRTX 5.0M
- NDRA 5.1M
- IPO Year
- XRTX N/A
- NDRA 2017
- Fundamental
- Price
- XRTX $1.33
- NDRA $4.54
- Analyst Decision
- XRTX Strong Buy
- NDRA Strong Buy
- Analyst Count
- XRTX 1
- NDRA 1
- Target Price
- XRTX $14.00
- NDRA $14,000.00
- AVG Volume (30 Days)
- XRTX 22.7K
- NDRA 709.8K
- Earning Date
- XRTX 11-29-2024
- NDRA 11-15-2024
- Dividend Yield
- XRTX N/A
- NDRA N/A
- EPS Growth
- XRTX N/A
- NDRA N/A
- EPS
- XRTX N/A
- NDRA N/A
- Revenue
- XRTX N/A
- NDRA N/A
- Revenue This Year
- XRTX N/A
- NDRA N/A
- Revenue Next Year
- XRTX N/A
- NDRA N/A
- P/E Ratio
- XRTX N/A
- NDRA N/A
- Revenue Growth
- XRTX N/A
- NDRA N/A
- 52 Week Low
- XRTX $1.09
- NDRA $4.41
- 52 Week High
- XRTX $7.00
- NDRA $4,882.50
- Technical
- Relative Strength Index (RSI)
- XRTX 41.92
- NDRA 31.46
- Support Level
- XRTX $1.29
- NDRA $5.23
- Resistance Level
- XRTX $1.42
- NDRA $8.80
- Average True Range (ATR)
- XRTX 0.15
- NDRA 1.58
- MACD
- XRTX -0.01
- NDRA -0.06
- Stochastic Oscillator
- XRTX 18.75
- NDRA 1.73
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.